Pharming Group N.V.
Yahoo Finance • last year
Pharming announces first patient dosed in pediatric clinical trial for children aged 1 to 6 years for leniolisib
The multinational Phase III study is evaluating a new pediatric granulated formulation of leniolisib in children aged 1 to 6 years with APDS, a rare primary immunodeficiency Leiden, The Netherlands, November 21, 2023: Pharming Group N.V.... Full story
Yahoo Finance • 2 years ago
Sequana Medical announces results of Special General Meeting of Shareholders
PRESS RELEASE REGULATED INFORMATION 26 June 2023,06:00 pm CEST Dr. Kenneth Macleod appointed as non-executive director Ghent, Belgium – 26 June 2023– Sequana Medical NV (Euronext Brussels: SEQUA) (the "Company" or "SequanaMedical"), a... Full story
Yahoo Finance • 2 years ago
Pharming to attend the H.C. Wainwright BioConnect Investor Conference 2023
LEIDEN, Netherlands, April 26, 2023 /PRNewswire/ -- Pharming Group N.V. ("Pharming") (Euronext Amsterdam: PHARM) (Nasdaq: PHAR) announces that Pharming's Chief Executive Officer, Sijmen de Vries will attend the H.C. Wainwright BioConnect I... Full story
Yahoo Finance • 2 years ago
Pharming Group convenes the Annual General Meeting of Shareholders 2023
LEIDEN, Netherlands, April 5, 2023 /PRNewswire/ -- Pharming Group N.V. ("Pharming" or "the Company") (Euronext: PHARM) (Nasdaq: PHAR) announces that the Company's 2023 Annual General Meeting of Shareholders (AGM) will be held on Wednesday,... Full story
Yahoo Finance • 2 years ago
Dutch biotech Pharming says it held $45 mln in collapsed SVB
AMSTERDAM, March 12 (Reuters) - Dutch biotech firm Pharming said on Sunday it held $45 million in collapsed U.S. lender Silicon Valley Bank's British and U.S. units and that it will seek to recover the funds. Pharming said it held $26 mil... Full story
Yahoo Finance • 2 years ago
Pharming Group Notice of Q3 Results
LEIDEN, Netherlands, Oct. 12, 2022 /PRNewswire/ -- Pharming Group N.V. ("Pharming" or "the Company") (Euronext Amsterdam: PHARM) (Nasdaq: PHAR) confirms it will announce financial results for the nine months ended September 30, 2022 on Thu... Full story
Yahoo Finance • 2 years ago
Pharming submits a Marketing Authorisation Application to the European Medicines Agency for Leniolisib
Application is based on randomized, controlled and long-term extension data for leniolisib as a treatment for APDS, a rare primary immunodeficiency This submission follows the grant of accelerated assessment allowing an expedited review f... Full story
Yahoo Finance • 3 years ago
Pharming Announces Presentation of Positive Results of Phase III Leniolisib Trial in APDS at Clinical Immunology Society 2022 Annual Meeting
Principal Investigator Dr. V. Koneti Rao Will Share Data Supporting the Investigational Treatment for Activated PI3K Delta Syndrome (APDS) LEIDEN, Netherlands, March 28, 2022 /PRNewswire/ -- Pharming Group N.V. ("Pharming" or "the Company... Full story
